TDP-43, Proteintech, 10782-2-AP

Proteintech 10782-2-AP · TDP-43 · pAb · Rabbit
4.06
(Overall rating from 1 review)
#5 of 21 targeting TDP-43
4.06
From 1 review · #5 of 21 for TDP-43

Information about this antibody

Target
Catalog No
10782-2-AP
Application
N/A
Clonality
pAb
Origin
Rabbit
Reactivity
N/A
Conjugation
N/A
Product Link
N/A
Clone ID
-

Vendor notes

No vendor notes available for this antibody.

pAbmAbs Average Ratings

ℹ
Western Blot
4.27
Immunostaining
3.65
IP
3.19
Overall
4.06

User Reviews (1)

Review of: TDP-43, Proteintech, 10782-2-AP by pAbmAbs Data Mining

Reviewed: May 8, 2026

Our team has carried out deep research in the published scientific literature to identify papers and reports using antibodies directed against human TCP-43 and followed up by extraction and evaluation of the available data to assess its performance according to pAbmAbs rating criteria.

YCharOS is here conducting a large head-to-head study comparing 18 commercial research antibodies against human TDP-43 encoded by TARDBP

The collection of antibodies was tested using HAP1 WT and TARDBP KO cells in the applications WB (WT and KO cell lysates/50 µg protein), IP (WT cell lysate) and IF (WT and KO cells) according to YCharOS standard protocols (see reference).

In WB (1:5000 ab dilution) 10782-2-AP detected a band of appr. 45 kDa in WT cell lysate along with a faint band of lower molecular weight. No bands were detected in KO cell lysate. A band was detected following IP (2 µg Ab used), this band was more intense compared to band in input extract (4% of starting material). A faint band was also detected in immunodepleted extract (4% of total unbound fraction), showing that the antibody does not completely deplete the antigen from cell lysate. In IF (1:400 ab dilution) a clear stain of WT cells was observed compared to KO cells showing some background.

We highly encourage other scientists to share their observations.

Western Blot
Immunostaining
IP

Submit Your Review of TDP-43, Proteintech, 10782-2-AP

Please log in to submit a review.